labafenogene marselecobac

·Code: SYNB1934

labafenogene marselecobac: developed by 1 company. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
SYNLOGIC, INC. (SYBX)Phase 3

Get deeper analysis on labafenogene marselecobac

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    labafenogene marselecobac — Drug Pipeline, Trials & FDA Status | BioSniper